United States Proton Therapy Market Forecast

United States Proton Therapy Market has potential to surpass US$ 16 Billion by 2024

United States Proton Therapy Market Analyst View: United States proton therapy market has potential to surpass US$ 16 Billion by the end of 2024.

Press Release Title: United States Proton Therapy Market has potential to surpass US$ 16 Billion by 2024 For more Info: https://www.renub.com/united-states-proton-therapy-market-nd.php

Get Free Customization in this Report Report Title: United States Proton Therapy Market, Patients by 14 Cancer Types (Central

Nervous

System

Tumors,

Intraocular

Melanomas

Cancer,

Pituitary

Neoplasms Cancer, Base of Skull / Axial Skeleton Cancer, Head and Neck Cancer, Lung Cancer, Retroperitoneal Sarcoma Cancer, Pediatric Cancer Cases (Up to Age 18), Gastrointestinal Tract Cancer, Urinary Tract Cancer, Female Pelvic Organs Cancer, Prostate Cancer, Breast Cancer & Other Cancer) Reimbursement Policies & Persons Treated at Centers Access Full Research: https://www.renub.com/united-states-proton-therapy-market-and-forecast-reimbursementpolicy-patients-treated-at-proton-therapy-centers-1045-p.php Š Renub Research

Page 1 of 6

www.renub.com

United States Proton Therapy Market has potential to surpass US$ 16 Billion by 2024 United States is the global market leader in proton therapy technology. It started its first center Loma Linda (LLUMC) in early 1990. In 2010, it has eight proton therapy operational centers and further this figure increased more than three times in 2017. Moreover there are many proton therapy centers in pipelines (under-construction and planning phase).

Proton therapy is one of the popular techniques in particle therapy that has many advantages over other like carbon, photon and ions. It delivers the proton exactly on the spot without affecting the surrounding area or very minimal damage of surrounding parts. Therefore it has mitigate the side effect to the great extent than other particle therapy techniques. Proton therapy is gaining prominence due to its non-invasive technique and highly effectiveness.

Request a free sample copy of the report: https://www.renub.com/contactus.php Rising Cancer Incidence in United States Propels Growth of Proton Therapy Market Cancer incidence in United States is reaching at tipping point. In 2016, 1.6 Million people diagnosed with cancer and it is projected to increase in coming future. The cancer mortality rate in United States is also very high; around 595,690 people died from the cancer in 2016.

Moreover there are many cancers that are very complicated and several difficulties are occurred during conventional surgical therapy. Proton therapy is advance and effective therapy that perform better results over conventional therapy. The number of proton therapy center in United States is increasing with rapid pace to make this technology accessible to large number of patients. Although diagnosed cancer patients number are too high than the actual number of cancer patients treated with proton therapy. According to Renub Research, United States Proton Therapy Market has potential to surpass US$ 16 Billion by the end of 2024.

Š Renub Research

Page 2 of 6

www.renub.com

United States Proton Therapy Market has potential to surpass US$ 16 Billion by 2024

Advancement of Proton Therapy Technology will further add the Procedural Effectiveness The research and development of proton therapy has been happening since last four decade and technology has been commercially in operation since last three decades. In current outlook manufacturer developed compact cyclotron, advanced delivery systems. The introduction of robotics in proton therapy systems increased efficiency in the management of patient transport, patient treatment positioning, treatment appliances, and imaging systems. Moreover the paradigm-shift of large proton therapy equipment into compact tools creates investment feasibility for industry players and mitigates some sort of entry barriers. Currently many small hospital and medical institutions are also investing in proton therapy to make it widely accessible.

Client can Purchase this Report in Sections from below link: Access full Research: https://www.renub.com/united-states-proton-therapy-marketand-forecast-reimbursement-policy-patients-treated-at-proton-therapy-centers1045-p.php Proton Therapy provides Treatment Opportunities for Recurrent Cancer As per the historical facts about cancer, recurrence cancer has been very difficult to treat; because large number of cancer patients is not opting for surgery. In such situation, the patients with reoccurrence cancer offered palliative options as a last resort to manage pain.

Proton therapy is effective in managing recurrence kind of cancer because it has ability to target a pinpoint of tumor and completely destroy it without affecting nearby healthy tissues.

Proton therapy established high credibility and acceptance among patients to treat high-risk cancer disease.

Key Topics Covered: 1.

Executive Summary

2.

Market (Actual & Potential) – United States Proton Therapy Market (2009 – 2024)

2.1

Actual Proton Therapy Market

2.2

Potential Proton Therapy Market

3.

Number of Patients – United States Proton Therapy (2009 – 2024)

3.1

Actual Numbers

3.2

Potential Numbers

4.

Cancer Types – Patients Number in United States Proton Therapy (2009 – 2024)

4.1

Central Nervous System Tumors

4.2

Intraocular Melanomas Cancer

© Renub Research

Page 3 of 6

www.renub.com

United States Proton Therapy Market has potential to surpass US$ 16 Billion by 2024 4.3

Pituitary Neoplasms Cancer

4.4

Base of Skull / Axial Skeleton Cancer

4.5

Head and Neck Cancer

4.6

Lung Cancer

4.7

Retroperitoneal Sarcoma Cancer

4.8

Pediatric Cancer Cases (Up to Age 18)

4.9

Gastrointestinal Tract Cancer

4.10

Urinary Tract Cancer

4.11

By Female Pelvic Organs Cancer

4.12

Prostate Cancer

4.13

Breast Cancer

4.14

Other Cancer

5.

Cancer Types – United States Proton Therapy Market (2009 – 2024)

5.1

Central Nervous System Tumors

5.2

Intraocular Melanomas Cancer

5.3

Pituitary Neoplasms Cancer

5.4

Base of Skull / Axial Skeleton Cancer

5.5

Head and Neck Cancer

5.6

Lung Cancer

5.7

Retroperitoneal Sarcoma Cancer

5.8

Pediatric Cancer (Up to Age 18)

5.9

Gastrointestinal Tract Cancer

5.10

Urinary Tract Cancer

5.11

Female Pelvic Organs Cancer

5.12

Prostate Cancer

5.13

Breast Cancer

5.14

Other Cancer

6.

United States – List of Proton Therapy Centers

6.1

Operating Proton Therapy Centers

6.2

Under-Construction Therapy Centers

6.3

Planning Proton Therapy Centers

7.

By Centers – Number of Proton Therapy Patients Treated

7.1

Loma Linda (LLUMC) Proton Therapy Center (2008 – 2016)

© Renub Research

Page 4 of 6

www.renub.com

United States Proton Therapy Market has potential to surpass US$ 16 Billion by 2024 7.2

UCSF – CNL Proton Therapy Center (2008 – 2015)

7.3

Boston (NPTC) Proton Therapy Center (2008 – 2016)

7.4

Bloomington (MPRI, 2) Proton Therapy Center (2008 – 2014)

7.5

Houston (MD Anderson) Proton Therapy Center (2008 – 2016)

7.6

UFPTI Jacksonville Proton Therapy Center (2008 – 2016)

7.7

Oklahoma City (ProCure PTC) Proton Therapy Center (2009 – 2017)

7.8

CDH Warrenville Proton Therapy Center (2010 – 2016)

7.9

Philadelphia (Upenn) Proton Therapy Center (2011 – 2016)

7.10

Hampton (HUPTI) Proton Therapy Center (2012 – 2016)

7.11

New Jersey (ProCure PTC) Proton Therapy Center (2012 – 2016)

7.12

Seattle (SCCA ProCure PTC) Proton Therapy Center (2013 – 2016)

7.13

St. Louis (S. Lee King PTC) Proton Therapy Center (2013 – 2016)

7.14

Provision Center for Proton Therapy, Knoxville, TN (2014 – 2016)

7.15

San Diego (Scripps PTC) (2014 – 2017)

7.16

Shreveport (Willis Knighton) Proton Therapy Center (2014 – 2017)

7.17

Jacksonville (Ackerman CC) Proton Therapy Center (2015 - 2016)

7.18

Rochester (Mayo PBTC) Proton Therapy Center (2015 - 2016)

7.19

Brunswick (Laurie PC) Proton Therapy Center (2015)

7.20

Irving (Texas Center for PT) Proton Therapy Center (2015 - 2017)

7.21

Memphis (St. Jude PTC) Proton Therapy Center (2015 - 2017)

7.22

Phoenix (Mayo PBTC) Proton Therapy Center (2016)

7.23

Baltimore (Maryland PTC) Proton Therapy Center (2016)

7.24

Cincinnati (Children's PTC) Proton Therapy Center (2016)

7.25

Orlando (Orlando Health PTC) Proton Therapy Center (2016)

7.26

Cleveland (UH Sideman PTC) Proton Therapy Center (2016)

8.

Proton Therapy – Reimbursement Policies

8.1

Proton Therapy Reimbursement Policies for Patients

8.2

Proton Therapy Reimbursement for Institutions, Stakeholders and Manufacturers

9.

Components of a Standard Proton Therapy Center

9.1

Proton Accelerator

9.2

Beam Transport System

9.3

Beam Delivery System

9.4

Nozzle

© Renub Research

Page 5 of 6

www.renub.com

United States Proton Therapy Market has potential to surpass US$ 16 Billion by 2024 9.5

Treatment Planning System

9.6

Image Viewers

9.7

Patient Positioning System (PPS)

9.8

Human Resource

10.

Company Analysis (2010 – 2021)

10.1

IBA Proton Therapy

10.2

Varian Medical Systems

10.3

Elekta

11. Driving Factors for Proton Therapy (Due to data confidentiality, driving factors have not been disclosed in this table of contents) 11.1

Point No. 1

11.2

Point No. 2

12. Challenges in Proton Therapy (Due to data confidentiality, challenges have not been disclosed in this table of contents) 12.1

Point no. 1

12.2

Point No. 2

Medical DevicesMarket Reports: https://www.renub.com/medical-devices-15-c.php

Renub Research - North America

Renub Research - Asia

Rajat Gupta

Ankit Mishra

225 Kristie Ln, Roswell

C – 86, Sector – 10

Georgia 30076, United States

Noida 201301, India

Tel: +1-678-302-0700

Tel: +91-120-421-9822

Email: info@renub.com

Email: info@renub.com

https://www.renub.com/

https://www.renub.com/

© Renub Research

Page 6 of 6

www.renub.com